Effective in Europe from February 2019, EU directive 2011/62/EU, also referred to as EU-FMD, aims to reduce counterfeiting of prescription drugs by tracking and tracing the passage of drugs through the entire supply chain. Watch below to learn what is required to achieve compliance.
With one year to go for pharmaceutical manufacturers, packaging sites and Marketing Authorisation Holders (MAHs) to achieve compliance with the Falsified Medicines Directive, watch the video below to learn about what is required and what your solution from Antares Vision and Crest Solutions could look like.
The team in Crest Solutions is here to help - we still have limited space for new clients to advise and implement solutions in time for the deadline in 2019.
Join other leading professionals in the world of pharmaceutical compliance and receive our updates directly to your mailbox - sign up to the Crest Solutions mailing list below. In 2018 we will be continuing our campaign with a monthly countdown on achieving compliance on the EU FMD.
Sign up to receive our monthly newsletter and updates.